Show
Sort by
-
Genome wide expression, mutation and methylation analysis validates three new mouse models for neuroblastoma targeting MYCN, ALK and LIN28B for pre-clinical studies
-
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
-
Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma
-
- Journal Article
- A1
- open access
N-Cadherin in neuroblastoma disease : expression and clinical significance
-
Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas
-
- Journal Article
- A1
- open access
Cancer gene prioritization for targeted resequencing using fitSNP scores
-
- Journal Article
- A1
- open access
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.
-
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice
-
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
-
Promoter methylation analysis identifies prognostic methylation biomarkers in neuroblastoma